TRAPPC5
gene geneOn this page
Also known as MGC52424TRS31
Summary
TRAPPC5 (trafficking protein particle complex subunit 5, HGNC:23067) is a protein-coding gene on chromosome 19p13.2, encoding Trafficking protein particle complex subunit 5 (Q8IUR0). May play a role in vesicular transport from endoplasmic reticulum to Golgi. It is a common-essential gene (DepMap: required in 94.5% of cancer cell lines).
Predicted to be involved in endoplasmic reticulum to Golgi vesicle-mediated transport. Part of TRAPP complex.
Source: NCBI Gene 126003 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 23 total
- Druggable target: yes
- Cancer dependency (DepMap): dependent in 94.5% of screened cell lines (common-essential)
- MANE Select transcript:
NM_001042462
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23067 |
| Approved symbol | TRAPPC5 |
| Name | trafficking protein particle complex subunit 5 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC52424, TRS31 |
| Ensembl gene | ENSG00000181029 |
| Ensembl biotype | protein_coding |
| Entrez | 126003 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 protein_coding
ENST00000317378, ENST00000426877, ENST00000595985, ENST00000596148, ENST00000944764
RefSeq mRNA: 3 — MANE Select: NM_001042462
NM_001042461, NM_001042462, NM_174894
CCDS: CCDS42490
Canonical transcript exons
ENST00000596148 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003027165 | 7680833 | 7680878 |
| ENSE00003493590 | 7682242 | 7687703 |
Expression profiles
Bgee: expression breadth ubiquitous, 133 present calls, max score 98.20.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 91.2116 / max 521.7233, expressed in 1828 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 173596 | 90.3263 | 1828 |
| 208677 | 0.8853 | 588 |
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 98.20 | gold quality |
| right testis | UBERON:0004534 | 98.04 | gold quality |
| stromal cell of endometrium | CL:0002255 | 97.70 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 97.61 | gold quality |
| prefrontal cortex | UBERON:0000451 | 97.48 | gold quality |
| primary visual cortex | UBERON:0002436 | 97.45 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 97.43 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 97.01 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 96.85 | gold quality |
| granulocyte | CL:0000094 | 96.78 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 96.48 | gold quality |
| testis | UBERON:0000473 | 96.02 | gold quality |
| frontal cortex | UBERON:0001870 | 95.41 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 94.72 | gold quality |
| cerebral cortex | UBERON:0000956 | 94.58 | gold quality |
| blood | UBERON:0000178 | 94.48 | gold quality |
| putamen | UBERON:0001874 | 94.34 | gold quality |
| bone marrow cell | CL:0002092 | 94.20 | gold quality |
| apex of heart | UBERON:0002098 | 94.10 | gold quality |
| leukocyte | CL:0000738 | 93.87 | gold quality |
| temporal lobe | UBERON:0001871 | 93.78 | gold quality |
| monocyte | CL:0000576 | 93.71 | gold quality |
| amygdala | UBERON:0001876 | 93.68 | gold quality |
| Ammon’s horn | UBERON:0001954 | 93.68 | gold quality |
| nucleus accumbens | UBERON:0001882 | 93.67 | gold quality |
| caudate nucleus | UBERON:0001873 | 93.50 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 93.48 | gold quality |
| brain | UBERON:0000955 | 93.29 | gold quality |
| bone marrow | UBERON:0002371 | 93.24 | gold quality |
| cortex of kidney | UBERON:0001225 | 93.14 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 5.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-4 | yes | 179.42 |
| E-MTAB-7037 | yes | 115.26 |
| E-HCAD-6 | yes | 38.86 |
| E-CURD-112 | yes | 20.17 |
| E-ANND-3 | yes | 11.32 |
Regulation
Is transcription factor: no
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 94.5% of screened cell lines, common-essential.
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | trappc5 | ENSDARG00000026068 |
| mus_musculus | Trappc5 | ENSMUSG00000040236 |
| rattus_norvegicus | Trappc5 | ENSRNOG00000001003 |
| drosophila_melanogaster | Trs31 | FBGN0266723 |
| caenorhabditis_elegans | WBGENE00013259 |
Protein
Protein identifiers
Trafficking protein particle complex subunit 5 — Q8IUR0 (reviewed: Q8IUR0)
All UniProt accessions (2): Q8IUR0, M0QZQ8
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in vesicular transport from endoplasmic reticulum to Golgi.
Subunit / interactions. Component of the multisubunit TRAPP (transport protein particle) complex, which includes at least TRAPPC2, TRAPPC2L, TRAPPC3, TRAPPC3L, TRAPPC4, TRAPPC5, TRAPPC8, TRAPPC9, TRAPPC10, TRAPPC11 and TRAPPC12.
Subcellular location. Golgi apparatus. cis-Golgi network. Endoplasmic reticulum.
Similarity. Belongs to the TRAPP small subunits family. BET3 subfamily.
RefSeq proteins (3): NP_001035926, NP_001035927, NP_777554 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007194 | TRAPP_component | Family |
| IPR016696 | TRAPP-I_su5 | Family |
| IPR024096 | NO_sig/Golgi_transp_ligand-bd | Homologous_superfamily |
Pfam: PF04051
UniProt features (3 total): chain 1, modified residue 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IUR0-F1 | 85.79 | 0.57 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 10
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-204005 | COPII-mediated vesicle transport |
| R-HSA-8876198 | RAB GEFs exchange GTP for GDP on RABs |
MSigDB gene sets: 109 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP, GOBP_VESICLE_LOCALIZATION, GOBP_VESICLE_ORGANIZATION, GOBP_VESICLE_TARGETING, GOBP_VESICLE_MEDIATED_TRANSPORT, REACTOME_MEMBRANE_TRAFFICKING, GOBP_ENDOPLASMIC_RETICULUM_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT, HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP, GOBP_MEMBRANE_ORGANIZATION, BURTON_ADIPOGENESIS_PEAK_AT_24HR, GOBP_ORGANELLE_LOCALIZATION, LEE_AGING_CEREBELLUM_UP, MARSON_BOUND_BY_FOXP3_STIMULATED, GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT, chr19p13
GO Biological Process (6): endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888), vesicle coat assembly (GO:0006901), COPII vesicle coat assembly (GO:0048208), obsolete vesicle tethering (GO:0099022), vesicle-mediated transport (GO:0016192), Golgi vesicle transport (GO:0048193)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (8): cytoplasm (GO:0005737), endoplasmic reticulum (GO:0005783), cytosol (GO:0005829), TRAPP complex (GO:0030008), TRAPPI protein complex (GO:1990070), TRAPPII protein complex (GO:1990071), TRAPPIII protein complex (GO:1990072), Golgi apparatus (GO:0005794)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| ER to Golgi Anterograde Transport | 1 |
| Rab regulation of trafficking | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 4 |
| TRAPP complex | 3 |
| cellular anatomical structure | 2 |
| endomembrane system | 2 |
| intracellular membrane-bounded organelle | 2 |
| Golgi apparatus | 2 |
| intercellular transport | 1 |
| intracellular transport | 1 |
| Golgi vesicle transport | 1 |
| vesicle budding from membrane | 1 |
| vesicle organization | 1 |
| vesicle coat assembly | 1 |
| protein-containing complex assembly | 1 |
| COPII-coated vesicle budding | 1 |
| transport | 1 |
| cellular process | 1 |
| vesicle-mediated transport | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| vesicle tethering complex | 1 |
| intracellular protein-containing complex | 1 |
| endoplasmic reticulum-Golgi intermediate compartment | 1 |
| endosome | 1 |
Protein interactions and networks
STRING
1150 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TRAPPC5 | TRAPPC6A | O75865 | 998 |
| TRAPPC5 | TRAPPC1 | Q9Y5R8 | 998 |
| TRAPPC5 | TRAPPC4 | Q9Y296 | 998 |
| TRAPPC5 | TRAPPC2 | P0DI81 | 997 |
| TRAPPC5 | TRAPPC3 | O43617 | 997 |
| TRAPPC5 | TRAPPC8 | Q9Y2L5 | 980 |
| TRAPPC5 | TRAPPC9 | Q96Q05 | 938 |
| TRAPPC5 | TRAPPC10 | P48553 | 882 |
| TRAPPC5 | TRAPPC13 | A5PLN9 | 775 |
| TRAPPC5 | TRAPPC12 | Q8WVT3 | 766 |
| TRAPPC5 | RAB1A | P11476 | 761 |
| TRAPPC5 | TRAPPC11 | Q7Z392 | 744 |
| TRAPPC5 | TRAPPC6B | Q86SZ2 | 676 |
| TRAPPC5 | TRAPPC2L | Q9UL33 | 667 |
| TRAPPC5 | SETX | Q7Z333 | 505 |
IntAct
116 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MED20 | MED19 | psi-mi:“MI:0914”(association) | 0.840 |
| RUFY4 | NDC80 | psi-mi:“MI:0914”(association) | 0.830 |
| CCNDBP1 | TRAPPC5 | psi-mi:“MI:0915”(physical association) | 0.780 |
| TRAPPC5 | CCNDBP1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| TRAPPC3 | TRAPPC5 | psi-mi:“MI:0915”(physical association) | 0.740 |
| TUBA1C | TXNDC9 | psi-mi:“MI:0914”(association) | 0.730 |
| RAB3IP | TRAPPC3 | psi-mi:“MI:0914”(association) | 0.700 |
| KANK4 | TRAPPC3 | psi-mi:“MI:0914”(association) | 0.640 |
| PTGR3 | DBT | psi-mi:“MI:0914”(association) | 0.640 |
| IL13RA2 | CHEK1 | psi-mi:“MI:0914”(association) | 0.640 |
| TRAPPC5 | HMG20A | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAPPC2 | TRAPPC5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAPPC2L | TRAPPC13 | psi-mi:“MI:0914”(association) | 0.560 |
| IL13RA2 | METTL15 | psi-mi:“MI:0914”(association) | 0.530 |
| NPY2R | RTL8C | psi-mi:“MI:0914”(association) | 0.530 |
| BTBD1 | TRAPPC10 | psi-mi:“MI:0914”(association) | 0.530 |
| TRAPPC1 | TRAPPC13 | psi-mi:“MI:0914”(association) | 0.530 |
| TPCN2 | AP3B1 | psi-mi:“MI:0914”(association) | 0.530 |
| BCL2L14 | CHEK1 | psi-mi:“MI:0914”(association) | 0.530 |
| CABS1 | TRAPPC10 | psi-mi:“MI:0914”(association) | 0.530 |
| PRAMEF17 | CUL2 | psi-mi:“MI:0914”(association) | 0.530 |
| LPAR1 | TMEM223 | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (189): TRAPPC5 (Two-hybrid), TRAPPC5 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC3 (Co-fractionation), TRAPPC5 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC1 (Affinity Capture-MS)
ESM2 similar proteins: A7RWP6, B4GW22, B4NC41, F1QMV3, F4JWP9, O43617, O55013, P34605, P36149, P45437, Q02880, Q08DS5, Q29G21, Q29G82, Q2NL13, Q32L78, Q4KL14, Q5BLF0, Q5F359, Q5R7L4, Q5RC82, Q5T215, Q5U1Z2, Q5ZI57, Q61IU9, Q62991, Q6GNS3, Q6P2Z0, Q6P2Z6, Q803N9, Q86K94, Q86SZ2, Q8AVM7, Q8BRF7, Q8IUR0, Q8K224, Q8WVM8, Q96D46, Q98SP7, Q99MH9
Diamond homologs: P15847, Q03337, Q2NL13, Q54YG5, Q5F359, Q7KQM2, Q8IUR0, Q9CQA1, Q9P7N9, Q8SU25
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| TRAPPC5 | “form complex” | “TRAPP III complex, TRAPPC2 variant” | binding |
| TRAPPC5 | “form complex” | “TRAPP III complex, TRAPPC2B variant” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 108 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| RAB GEFs exchange GTP for GDP on RABs | 8 | 14.2× | 3e-05 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| obsolete vesicle tethering | 7 | 78.0× | 1e-09 |
| COPII vesicle coat assembly | 5 | 39.5× | 2e-05 |
| endoplasmic reticulum to Golgi vesicle-mediated transport | 9 | 13.7× | 4e-06 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
23 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 21 |
| Likely benign | 0 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
464 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:7682236:CCGCA:C | acceptor_loss | 1.0000 |
| 19:7682237:CGCAG:C | acceptor_loss | 1.0000 |
| 19:7682238:GCA:G | acceptor_loss | 1.0000 |
| 19:7682238:GCAGG:G | acceptor_loss | 1.0000 |
| 19:7682239:CA:C | acceptor_loss | 1.0000 |
| 19:7682240:A:AC | acceptor_loss | 1.0000 |
| 19:7682240:A:AG | acceptor_gain | 1.0000 |
| 19:7682240:AG:A | acceptor_gain | 1.0000 |
| 19:7682240:AGGGT:A | acceptor_gain | 1.0000 |
| 19:7682241:G:GG | acceptor_gain | 1.0000 |
| 19:7682241:GG:G | acceptor_gain | 1.0000 |
| 19:7682241:GGGT:G | acceptor_gain | 1.0000 |
| 19:7682241:GGGTG:G | acceptor_gain | 1.0000 |
| 19:7682838:GA:G | donor_gain | 1.0000 |
| 19:7682237:C:CA | acceptor_gain | 0.9900 |
| 19:7682240:AGG:A | acceptor_gain | 0.9900 |
| 19:7682241:G:GT | acceptor_gain | 0.9900 |
| 19:7682241:GGG:G | acceptor_gain | 0.9900 |
| 19:7682832:A:G | donor_gain | 0.9900 |
| 19:7680878:GGTGA:G | donor_loss | 0.9800 |
| 19:7680879:G:GA | donor_loss | 0.9800 |
| 19:7680880:T:A | donor_loss | 0.9800 |
| 19:7682779:G:GT | donor_gain | 0.9800 |
| 19:7682782:G:GT | donor_gain | 0.9800 |
| 19:7682899:A:AG | donor_gain | 0.9800 |
| 19:7682900:G:GG | donor_gain | 0.9800 |
| 19:7680881:G:GT | donor_loss | 0.9700 |
| 19:7680879:G:GG | donor_gain | 0.9600 |
| 19:7681012:G:GT | donor_gain | 0.9600 |
| 19:7682829:GAGA:G | donor_gain | 0.9600 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000083785 (19:7680485 C>T), RS1000136938 (19:7681974 G>A,C,T), RS1000190338 (19:7687348 G>A), RS1000464639 (19:7682298 C>T), RS1001069294 (19:7683587 G>C,T), RS1001094088 (19:7679301 CGTGT>C,CGT), RS1001289345 (19:7684049 G>A), RS1001541746 (19:7683313 G>A,T), RS1001734944 (19:7681232 G>A), RS1001967496 (19:7679156 T>C), RS1002110087 (19:7684568 C>T), RS1002482388 (19:7684859 T>G), RS1002579530 (19:7678903 C>A,G,T), RS1002969179 (19:7680321 C>T), RS1003001701 (19:7680079 G>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4295892 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression | 3 |
| Cadmium Chloride | increases abundance, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| decabromobiphenyl ether | affects expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| diallyl trisulfide | increases expression | 1 |
| ICG 001 | decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Carcinogens | decreases expression | 1 |
| Mutagens | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4118950 | Binding | Binding affinity to TRAPPC5 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay | Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors. — Bioorg Med Chem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.